SSTR2 and glioblastoma: Additionally, G-CIMP negative tumours (representing a more aggressive GBM phenotype) have significantly lower expression levels of SSTR1 and/or SSTR2 (Fig. 3E), but not CORT (data not shown), in the TCGA/Gravendeel/Murat-cohorts.